2022
DOI: 10.1007/s10006-022-01052-3
|View full text |Cite
|
Sign up to set email alerts
|

The genetic factors contributing to the risk of cleft lip-cleft palate and their clinical utility

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 81 publications
0
6
0
Order By: Relevance
“…It is known that polygenic nonsyndromic forms of orofacial clefts in humans can be associated with predisposing germinal DNA variants or fetal exposure to teratogenic factors, while syndromic forms can be caused by chromosomal aberrations or single gene mutation [27]. Chromosome analysis is commonly used in studies of congenital malformation.…”
Section: Discussionmentioning
confidence: 99%
“…It is known that polygenic nonsyndromic forms of orofacial clefts in humans can be associated with predisposing germinal DNA variants or fetal exposure to teratogenic factors, while syndromic forms can be caused by chromosomal aberrations or single gene mutation [27]. Chromosome analysis is commonly used in studies of congenital malformation.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the various factors that may cause CLP, medical professionals have developed treatments to address CLP problems that allow patients to live a healthier and better life (Martinelli et al, 2020). Genetic factors have also been reported to contribute to CLP disorders, such as chromosomal abnormalities and family history (Blue, 2012;Askarian, 2022;Ganatra et al, 2021). Certain genetic variants such as TBX22, IRF6, and PVRL1 have also been reported to be associated with CLP risk (Askarian, 2022).…”
Section: Cleft Lip/palatementioning
confidence: 99%
“…Although the signaling mechanisms for the fusion event are complex and not fully understood, certain signaling components have been revealed as key players and are investigated in this study, including transforming growth factor beta-3 (TGFβ3), bone morphogenetic proteins (BMPs), fibroblast growth factors (FGFs), interferon regulatory factor 6 (IRF6), Rhoassociated coil-coil kinase-1 (ROCK1), GABA receptors and ERK signaling, adhesion molecule E-cadherin, ECM matrix metalloproteinases (MMPs), and microtubule polymerization, usually through the use of mouse models. Many of these components have been confirmed in humans by identifying the genetic anomalies in human subjects with CP (Askarian et al, 2022;Baroni et al, 2006;Bush & Jiang, 2012;Kohli & Kohli, 2012;Reynolds et al, 2020). Mutations in genes IRF6, FGFRs, FGFs, BMP4, ROCK, RAR, and TGFβ3 have been identified as candidates responsible for CP in humans (Askarian et al, 2022;Bush & Jiang, 2012;Dixon et al, 2011;Palmieri et al, 2020;Reynolds et al, 2020;Schutte et al, 1993).…”
Section: Introductionmentioning
confidence: 98%
“…Many of these components have been confirmed in humans by identifying the genetic anomalies in human subjects with CP (Askarian et al, 2022;Baroni et al, 2006;Bush & Jiang, 2012;Kohli & Kohli, 2012;Reynolds et al, 2020). Mutations in genes IRF6, FGFRs, FGFs, BMP4, ROCK, RAR, and TGFβ3 have been identified as candidates responsible for CP in humans (Askarian et al, 2022;Bush & Jiang, 2012;Dixon et al, 2011;Palmieri et al, 2020;Reynolds et al, 2020;Schutte et al, 1993).…”
Section: Introductionmentioning
confidence: 98%